Brind.

Sanofi eliminated INOV investment value, while Ipsen and UCB acquired INOV portfolio companies.

1 report, 1 independent Updated Sep 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sanofi eliminated INOV investment value, while Ipsen and UCB acquired INOV portfolio companies.

Who's involved

What this event is mainly about
SanofiIpsenUCB

Keep exploring

The entities involved

  • Sanofi

    company in Milan, Italy

    Nothing else this week.

  • Ipsen

    company in Barcelona, Spain

    Nothing else this week.

  • UCB

    biopharmaceutical company headquartered in Brussels, Belgium

    Nothing else this week.

Coverage

Newest first; wire copies grouped